Recombinant Mouse Antibody ( F26G19) is capable of binding to SARS-CoV S, expressed in Chinese Hamster Ovary cells (CHO).
Figure 1 ELISA reactivity of mAbs with whole, inactivated SARS-CoV.
Hybridoma supernatants were tested at a 1:4 dilution in PBS + 0.2% BSA on pre-blocked plates, coated with 18 ng per well of inactivated, highly purified SARS-CoV. Positive clones were identified as having positive binding (color) in wells that were at least four-fold higher than the background level reactivity on BSA. Antigen legend: black bars—native, highly purified SARS-CoV; white bars—heat denatured, highly purified SARS-CoV; grey bars—BSA control.
Berry, J. D., Jones, S., Drebot, M. A., Andonov, A., Sabara, M., Yuan, X. Y., ... & Nicolas, B. (2004). Development and characterisation of neutralising monoclonal antibody to the SARS-coronavirus. Journal of virological methods, 120(1), 87-96.
Figure 2 Western immunoblot reactivity of mAbs with highly purified SARS-CoV.
The positive and preimmune control sera were from the corresponding immune mouse and tested at 1:2000 dilution in TBS + 0.2% BSA. Lanes marked 1 were loaded with highly purified SARS-CoV, lanes marked 2 with infected Vero cell lysate. The molecular weights of the pre-stained kaleidoscope markers (BioRAD) are indicated on the left of the figure.
Berry, J. D., Jones, S., Drebot, M. A., Andonov, A., Sabara, M., Yuan, X. Y., ... & Nicolas, B. (2004). Development and characterisation of neutralising monoclonal antibody to the SARS-coronavirus. Journal of virological methods, 120(1), 87-96.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
CAT | Product Name | Application | Type |
---|---|---|---|
MRO-610LC | Human Anti-SARS-CoV S Recombinant Antibody (MRO-610LC) | ELISA, Neut | Human IgG1, κ |
MRO-611LC | Human Anti-SARS-CoV S Recombinant Antibody (MRO-611LC) | ELISA | Human IgG1, κ |
MRO-612LC | Human Anti-SARS-CoV S Recombinant Antibody (MRO-612LC) | ELISA | Human IgG1, κ |
MRO-613LC | Human Anti-SARS-CoV S Recombinant Antibody (MRO-613LC) | ELISA | Human IgG1, κ |
MRO-614LC | Human Anti-SARS-CoV S Recombinant Antibody (MRO-614LC) | ELISA | Human IgG1, κ |
CAT | Product Name | Application | Type |
---|---|---|---|
MRO-653LC | Mouse Anti-SARS-CoV S Recombinant Antibody (MRO-653LC) | ELISA | Mouse antibody |
MRO-653LC-F(E) | Mouse Anti-SARS-CoV S Recombinant Antibody; Fab Fragment (MRO-653LC-F(E)) | ELISA | Mouse Fab |
MRO-654LC-F(E) | Mouse Anti-SARS-CoV S Recombinant Antibody; Fab Fragment (MRO-654LC-F(E)) | ELISA | Mouse Fab |
MRO-655LC-F(E) | Anti-SARS-CoV S Recombinant Antibody Fab Fragment (S-9-11) | ELISA | Mouse antibody |
MRO-656LC-F(E) | Anti-SARS-CoV S Recombinant Antibody Fab Fragment (N-176-15) | ELISA | Mouse antibody |
CAT | Product Name | Application | Type |
---|---|---|---|
EPAF-1139CQ | Recombinant Human Anti-SARS-CoV S Antibody (m396) | ELISA | IgG1 |
CAT | Product Name | Application | Type |
---|---|---|---|
HPAB-1337WJ | Human Anti-SARS-CoV S Recombinant Antibody (HPAB-1337WJ) | ELISA, FC, WB, IHC, IP | Human IgG2 |
HPAB-1338WJ | Human Anti-SARS-CoV S Recombinant Antibody (HPAB-1338WJ) | ELISA, FC, WB, IHC, IP | Human IgG2 |
HPAB-1339WJ | Human Anti-SARS-CoV S Recombinant Antibody (HPAB-1339WJ) | ELISA, FC, WB, IHC, IP | Human IgG2 |
HPAB-1340WJ | Human Anti-SARS-CoV S Recombinant Antibody (HPAB-1340WJ) | ELISA, FC, WB, IHC, IP | Human IgG2 |
VS-0323-CJ47 | Chicken Anti-SARS-CoV S Recombinant Antibody (clone 4S1) | ELISA, WB, IF | Chicken IgY |
CAT | Product Name | Application | Type |
---|---|---|---|
HPAB-1337WJ-F(E) | Human Anti-SARS-CoV S Recombinant Antibody; Fab Fragment (HPAB-1337WJ-F(E)) | ELISA, FC, WB, IHC, IP | Human Fab |
HPAB-1338WJ-F(E) | Human Anti-SARS-CoV S Recombinant Antibody; Fab Fragment (HPAB-1338WJ-F(E)) | ELISA, FC, WB, IHC, IP | Human Fab |
HPAB-1339WJ-F(E) | Human Anti-SARS-CoV S Recombinant Antibody; Fab Fragment (HPAB-1339WJ-F(E)) | ELISA, FC, WB, IHC, IP | Human Fab |
HPAB-1340WJ-F(E) | Human Anti-SARS-CoV S Recombinant Antibody; Fab Fragment (HPAB-1340WJ-F(E)) | ELISA, FC, WB, IHC, IP | Human Fab |
HPAB-1341WJ-F(E) | Human Anti-SARS-CoV S Recombinant Antibody (clone 68); Fab Fragment | ELISA, WB | Human Fab |
CAT | Product Name | Application | Type |
---|---|---|---|
HPAB-1343WJ-S(P) | Human Anti-SARS-CoV S Recombinant Antibody (clone S217); scFv Fragment | ELISA, Neut | Human scFv |
HPAB-1344WJ-S(P) | Human Anti-SARS-CoV S Recombinant Antibody (clone S222); scFv Fragment | ELISA, Neut | Human scFv |
HPAB-1345WJ-S(P) | Human Anti-SARS-CoV S Recombinant Antibody (clone S223); scFv Fragment | ELISA, Neut | Human scFv |
HPAB-1346WJ-S(P) | Human Anti-SARS-CoV S Recombinant Antibody (clone S225); scFv Fragment | ELISA, Neut | Human scFv |
HPAB-1347WJ-S(P) | Human Anti-SARS-CoV S Recombinant Antibody (clone S226); scFv Fragment | ELISA, Neut | Human scFv |
CAT | Product Name | Application | Type |
---|---|---|---|
NAB-474CQ | Camelid Anti-SARS-CoV S Recombinant Single Domain Antibody (clone VHH-44) | Neut | Camelid VHH |
There are currently no Customer reviews or questions for PABW-114. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.